Burr Hole for Aspiration — Cost, Top Hospitals & Success Rates | MyMedicPlus

Burr hole aspiration is a neurosurgical procedure in which one or more small holes (typically 10-14mm in diameter) are drilled through the skull to access and drain intracranial fluid collections. The procedure is most commonly performed for chronic subdural hematoma (CSDH), where blood accumulates between the dura mater and the arachnoid membrane over weeks to months. It is one of the least invasive neurosurgical approaches and serves as both a diagnostic and therapeutic intervention.

Chronic subdural hematoma is a significant neurosurgical condition, with an incidence of approximately 1-5 per 100,000 people annually in the general population, rising to 58 per 100,000 in individuals over 70 years old. The aging population and increasing use of anticoagulant and antiplatelet medications have led to a rising incidence of this condition. CSDH accounts for the most common reason for neurosurgical intervention in elderly patients, and without treatment, it can lead to progressive neurological decline, disability, and death.

The treatment approach for intracranial fluid collections depends on the nature, volume, and chronicity of the collection, as well as the patient's neurological status. Burr hole aspiration is considered the gold standard first-line surgical treatment for chronic subdural hematoma due to its favorable balance of effectiveness, low complication rates, and tolerability in elderly and medically complex patients. The procedure can be performed under local anesthesia, making it suitable for patients who may not tolerate general anesthesia.

Burr hole aspiration is indicated for several intracranial pathologies requiring drainage of fluid collections. The primary conditions treated include:

• Chronic subdural hematoma (CSDH) — the most common indication, involving liquefied blood collections that develop over 2-3 weeks following head trauma, often in elderly patients on anticoagulants
• Subacute subdural hematoma — hematomas that are transitioning from solid to liquid phase, typically 3-21 days after injury
• Brain abscess — aspiration of purulent collections within the brain parenchyma for both diagnostic culture and therapeutic decompression
• Subdural empyema — infected fluid collections in the subdural space requiring urgent drainage
• Subdural hygroma — accumulation of cerebrospinal fluid in the subdural space, sometimes requiring drainage when symptomatic
• Intracranial cyst aspiration — decompression of symptomatic arachnoid cysts or other cystic lesions

Additionally, burr holes may be used for diagnostic purposes, such as obtaining tissue biopsies, placing intracranial pressure monitors, or inserting external ventricular drains for hydrocephalus management. The technique serves as a critical access point for multiple neurosurgical interventions.

Candidates for burr hole aspiration typically present with symptomatic intracranial fluid collections demonstrated on CT or MRI imaging. For chronic subdural hematoma, surgical intervention is generally recommended when the hematoma thickness exceeds 10mm, there is midline shift greater than 5mm, or the patient exhibits progressive neurological symptoms such as headache, confusion, hemiparesis, speech difficulties, or gait disturbance. Even asymptomatic patients with large collections may be considered for surgery.

One of the significant advantages of burr hole aspiration is its suitability for high-risk surgical patients. Elderly patients, those with multiple comorbidities, patients on anticoagulation therapy, and individuals with poor cardiopulmonary reserve can safely undergo this procedure under local anesthesia with sedation. The procedure is well-tolerated even in patients with ASA physical status class III-IV, making it accessible to a population that might not tolerate more invasive craniotomy.

Relative contraindications include acute subdural hematoma with solid clot (which requires craniotomy for evacuation), heavily calcified or organized chronic subdural hematoma that cannot be aspirated through a small opening, and multiloculated collections that may not drain adequately through a single burr hole. Uncorrected coagulopathy should be addressed before surgery, though the procedure can be performed urgently with concurrent reversal of anticoagulation. Patients with recurrent CSDH after multiple burr hole procedures may be better served by craniotomy or middle meningeal artery embolization.

The standard burr hole aspiration technique involves positioning the patient supine with the head turned to the opposite side of the collection. After local anesthesia infiltration and a small scalp incision, a burr hole is drilled through the skull at a location determined by the maximal thickness of the collection on imaging. For frontal collections, the burr hole is typically placed anterior to the coronal suture; for collections over the convexity, a parietal burr hole is used. Many surgeons place two burr holes (one frontal, one parietal) to allow irrigation between the openings.

Once the skull is penetrated, the dura is carefully opened with a cruciate incision, and the subdural membrane is breached. The fluid is allowed to drain under gravity and is supplemented by gentle irrigation with warm normal saline until the effluent runs clear. A closed drainage system (such as a Jackson-Pratt or subdural drain) is typically left in place for 24-48 hours post-operatively, as studies demonstrate that drain placement reduces recurrence rates from approximately 25% to 10%.

Alternative surgical approaches include twist-drill craniostomy, an even less invasive bedside procedure using a smaller drill that can be performed under local anesthesia alone, though it offers less exposure for irrigation. Mini-craniotomy provides a larger opening (3-5cm) for better visualization and is useful for organized or membranous collections. Endoscopic-assisted burr hole evacuation allows direct visualization and lysis of septations within multiloculated collections, improving drainage completeness.

Non-surgical alternatives include observation for small, asymptomatic collections and medical management with dexamethasone, which has shown promise in clinical trials for reducing hematoma volume without surgery. Middle meningeal artery embolization is an emerging endovascular technique that shows excellent results as an adjunct to or replacement for surgical drainage, with recurrence rates as low as 2-4% in recent studies.

Burr hole aspiration offers significant benefits as a first-line treatment for chronic subdural hematoma. The procedure achieves symptomatic improvement in 80-90% of patients, with many experiencing neurological recovery within hours to days of drainage. Headache, confusion, and focal neurological deficits typically resolve rapidly once the mass effect of the collection is relieved. Studies report good functional outcomes (modified Rankin Scale 0-2) in 70-80% of patients at 6 months post-procedure.

The minimally invasive nature of the procedure is a key advantage. Compared to craniotomy, burr hole aspiration has shorter operative time (30-60 minutes vs. 1-2 hours), lower blood loss, less post-operative pain, shorter hospital stay (3-5 days vs. 5-10 days), and lower perioperative complication rates. The ability to perform the procedure under local anesthesia makes it especially valuable for elderly and medically fragile patients who represent the majority of CSDH cases.

Mortality rates following burr hole aspiration for CSDH are low, typically reported at 0.5-2% in contemporary series, which primarily reflects the underlying comorbidities of the elderly patient population rather than procedural risk. Long-term outcomes are favorable, with most patients returning to their pre-morbid functional status. The procedure is also highly cost-effective compared to more invasive alternatives, with shorter operating room time, reduced ICU requirements, and earlier discharge.

While burr hole aspiration is considered a safe neurosurgical procedure, it carries certain risks. The most common complication is recurrence of the subdural collection, occurring in 10-20% of patients. Risk factors for recurrence include bilateral hematomas, hematoma density on CT (mixed-density collections recur more frequently), absence of post-operative drain placement, ongoing anticoagulation, and the presence of comorbidities such as liver disease or coagulopathy.

Acute subdural hematoma from tearing of bridging veins during drainage is a rare but serious complication occurring in approximately 1-2% of cases, potentially requiring emergency craniotomy. Intracerebral hemorrhage from cortical injury during catheter placement occurs in less than 1% of procedures. Tension pneumocephalus (excessive air entering the cranial cavity) can develop in 1-5% of cases if adequate saline replacement is not maintained during drainage.

Other complications include seizures (3-5%, usually within the first week), wound infection (1-3%), subdural empyema (rare, <1%), and brain re-expansion injury in cases of rapid drainage of large collections. Medical complications such as pulmonary embolism, pneumonia, and urinary tract infection are common in the elderly population undergoing this procedure and contribute more to morbidity than surgical complications per se. A 30-day mortality rate of 3-8% is reported in large series, primarily reflecting the frail patient demographic.

Immediate post-operative care involves monitoring in the neurosurgical unit or ICU for 24-48 hours. The subdural drain is kept at a level below the head to facilitate continued drainage and is typically removed after 24-48 hours when output has decreased to minimal amounts. Patients are kept flat or with minimal head elevation initially to promote brain re-expansion and are gradually mobilized as tolerated. Neurological assessments are performed regularly to detect any acute changes.

A post-operative CT scan is typically obtained within 24-48 hours to assess the degree of hematoma evacuation and rule for complications such as acute bleeding or pneumocephalus. Residual subdural fluid is expected and common on early post-operative imaging; complete resolution may take 4-6 weeks. Patients are usually discharged after 3-5 days if neurologically stable and without drain-related complications.

Follow-up CT scans are obtained at 2-4 weeks and 6-12 weeks post-operatively to monitor for hematoma resolution and detect recurrence. Anticoagulation and antiplatelet medications are gradually restarted in consultation with the prescribing physician, typically 1-2 weeks post-operatively depending on the indication and bleeding risk. Patients are advised to avoid strenuous activity and contact sports for 4-6 weeks. Long-term outcomes are generally favorable, with most patients recovering their baseline neurological function within 1-3 months.

The cost of burr hole aspiration is influenced by several variables. The urgency of the procedure significantly impacts cost, with emergency cases incurring higher facility and staffing fees compared to elective or semi-elective procedures. Whether the procedure is unilateral or bilateral, the type of anesthesia used (local with sedation vs. general), and the need for post-operative ICU care versus standard neurosurgical ward monitoring all affect the total cost.

Hospital stay duration is a major cost driver, typically ranging from 3-7 days depending on the patient's neurological recovery and any complications. Post-operative imaging (CT scans at multiple time points), subdural drain materials, and any additional interventions for recurrence or complications contribute to the overall expense. In cases of recurrence requiring repeat surgery, the cumulative cost increases substantially.

Geographic variations in healthcare costs are significant, with neurosurgical procedures in North America and Western Europe costing considerably more than equivalent procedures at accredited facilities in Asia, Eastern Europe, or Latin America. Insurance typically covers burr hole aspiration as it is a medically necessary procedure rather than elective surgery. Patients should factor in the cost of follow-up imaging, medications (antiepileptics if prescribed), and any rehabilitation services needed for neurological recovery.

Observation with serial imaging is appropriate for small, asymptomatic chronic subdural hematomas (less than 10mm thickness without significant midline shift). Approximately 15-25% of small collections resolve spontaneously over 1-3 months. Close neurological monitoring and repeat CT scanning are essential during the observation period, as delayed neurological deterioration can occur.

Medical management with corticosteroids, particularly dexamethasone, has emerged as a viable alternative or adjunct to surgery. The landmark Dex-CSDH trial demonstrated that dexamethasone reduced the need for surgical intervention in some patients, though concerns about complications in the elderly (hyperglycemia, infection risk) require careful patient selection. Atorvastatin and tranexamic acid have also shown promise in small studies for promoting hematoma resolution.

Middle meningeal artery (MMA) embolization is a rapidly evolving endovascular technique that blocks the arterial blood supply to the neomembranes responsible for hematoma recurrence. Recent randomized trials show MMA embolization significantly reduces recurrence rates when used alone or in combination with surgical drainage, with success rates exceeding 95%. Craniotomy remains the definitive surgical option for organized or calcified hematomas, multiloculated collections, or cases of recurrence after multiple burr hole procedures, providing the widest exposure for complete evacuation and membrane removal.